Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Brem

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Diagnostics (Basel, Switzerland)|January 11, 2025
Quantitative Physiologic MRI Combined with Feature Engineering for Developing Machine Learning-Based Prediction Models to Distinguish Glioblastomas from Single Brain MetastasesSeyyed Ali Hosseini, Stijn Servaes, Brandon Hall, et al.
Journal of Translational Medicine|September 24, 2016
Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 TeslaGaurav Verma, Suyash Mohan, MacLean P Nasrallah, et al.
Cancer Control : Journal of the Moffitt Cancer Center|August 4, 2006
Overall and progression-free survival in metastatic melanoma: analysis of a single-institution databaseM Aleem Khan, Stephanie Andrews, Roohi Ismail-Khan, et al.
Journal of Neuro-Oncology|January 10, 2016
Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patientsSydney M Evans, Mary Putt, Xiang-Yang Yang, et al.
Nuclear Medicine Communications|February 16, 2026
Somatostatin receptor PET in meningioma: diagnosis, therapy, and surveillanceJaskeerat Gujral, Om H Gandhi, Amir A Amanullah, et al.
Neuro-Oncology|October 27, 2011
Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastomaPrakash Chinnaiyan, Sajeel Chowdhary, Lisa Potthast, et al.
Journal of Neurosurgery|March 2, 2021
Second window ICG predicts gross-total resection and progression-free survival during brain metastasis surgeryClare W Teng, Steve S Cho, Yash Singh, et al.
Neuro-Oncology|May 13, 2022
Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort studyLauren Reed-Guy, Arati S Desai, Richard E Phillips, et al.
Journal of Neuro-Oncology|May 2, 2023
Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction modelLaiz Laura de Godoy, Sanjeev Chawla, Steven Brem, et al.
NMR in Biomedicine|December 18, 2018
Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastomaGaurav Verma, Sanjeev Chawla, Suyash Mohan, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Diagnostics (Basel, Switzerland)|January 11, 2025
Quantitative Physiologic MRI Combined with Feature Engineering for Developing Machine Learning-Based Prediction Models to Distinguish Glioblastomas from Single Brain MetastasesSeyyed Ali Hosseini, Stijn Servaes, Brandon Hall, et al.
Journal of Translational Medicine|September 24, 2016
Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 TeslaGaurav Verma, Suyash Mohan, MacLean P Nasrallah, et al.
Cancer Control : Journal of the Moffitt Cancer Center|August 4, 2006
Overall and progression-free survival in metastatic melanoma: analysis of a single-institution databaseM Aleem Khan, Stephanie Andrews, Roohi Ismail-Khan, et al.
Journal of Neuro-Oncology|January 10, 2016
Initial evidence that blood-borne microvesicles are biomarkers for recurrence and survival in newly diagnosed glioblastoma patientsSydney M Evans, Mary Putt, Xiang-Yang Yang, et al.
Nuclear Medicine Communications|February 16, 2026
Somatostatin receptor PET in meningioma: diagnosis, therapy, and surveillanceJaskeerat Gujral, Om H Gandhi, Amir A Amanullah, et al.
Neuro-Oncology|October 27, 2011
Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastomaPrakash Chinnaiyan, Sajeel Chowdhary, Lisa Potthast, et al.
Journal of Neurosurgery|March 2, 2021
Second window ICG predicts gross-total resection and progression-free survival during brain metastasis surgeryClare W Teng, Steve S Cho, Yash Singh, et al.
Neuro-Oncology|May 13, 2022
Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort studyLauren Reed-Guy, Arati S Desai, Richard E Phillips, et al.
Journal of Neuro-Oncology|May 2, 2023
Assessment of treatment response to dendritic cell vaccine in patients with glioblastoma using a multiparametric MRI-based prediction modelLaiz Laura de Godoy, Sanjeev Chawla, Steven Brem, et al.
NMR in Biomedicine|December 18, 2018
Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastomaGaurav Verma, Sanjeev Chawla, Suyash Mohan, et al.
Pageof 13